2023 Q3 Form 10-Q Financial Statement

#000121390023064517 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $155.00 $117.00
YoY Change 32.48% 178.57%
Cost Of Revenue $14.00 $12.00
YoY Change 16.67% 200.0%
Gross Profit $141.00 $105.00
YoY Change 34.29% 176.32%
Gross Profit Margin 90.97% 89.74%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.857K $6.854K
YoY Change -14.55% -31.63%
Operating Profit -$5.716K -$6.749K
YoY Change -15.31% -32.42%
Interest Expense $774.00 $459.00
YoY Change 68.63% 309.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$6.490K -$7.208K
YoY Change -9.96% -28.63%
Net Earnings / Revenue -4187.1% -6160.68%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.284M shares 5.284M shares 5.284M shares
Diluted Shares Outstanding 5.284M shares 5.284M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.162K $1.630K $355.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $3.661K $4.591K $4.656K
Prepaid Expenses $458.00 $1.833K $1.833K
Receivables
Other Receivables
Total Short-Term Assets $7.281K $8.054K $6.844K
YoY Change 14.9% 17.68%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $4.285K $4.693K
YoY Change -8.69%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $4.285K $4.693K
YoY Change -100.0% -8.69%
TOTAL ASSETS
Total Short-Term Assets $7.281K $8.054K $6.844K
Total Long-Term Assets $0.00 $4.285K $4.693K
Total Assets $7.281K $12.34K $11.54K
YoY Change -33.37% 6.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.310K
YoY Change
Accrued Expenses $5.012K $4.184K $1.569K
YoY Change 140.04% 166.67%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $105.7K $93.48K $55.71K
YoY Change 68.13% 67.81%
SHAREHOLDERS EQUITY
Retained Earnings -$202.9K -$185.7K -$148.7K
YoY Change 29.7% 24.87%
Common Stock $5.285K $5.285K $5.285K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$98.40K -$81.14K -$44.17K
YoY Change
Total Liabilities & Shareholders Equity $7.281K $12.34K $11.54K
YoY Change -33.37% 6.95%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$6.490K -$7.208K
YoY Change -9.96% -28.63%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5284318 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56301
dei Entity Registrant Name
EntityRegistrantName
OUTDOOR SPECIALTY PRODUCTS, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4854952
dei Entity Address Address Line1
EntityAddressAddressLine1
3842 Quail Hollow Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84109
dei City Area Code
CityAreaCode
(801)
dei Local Phone Number
LocalPhoneNumber
560-5184
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5284318 shares
CY2023Q2 us-gaap Cash
Cash
1630 usd
CY2022Q3 us-gaap Cash
Cash
1241 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1833 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
458 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
4591 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
4638 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
8054 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
6337 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4285 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4591 usd
CY2023Q2 us-gaap Assets
Assets
12339 usd
CY2022Q3 us-gaap Assets
Assets
10928 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4184 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2088 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
89299 usd
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
60769 usd
CY2023Q2 us-gaap Liabilities
Liabilities
93483 usd
CY2022Q3 us-gaap Liabilities
Liabilities
62857 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5284318 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5284318 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5284318 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5284318 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5285 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5285 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99232 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99232 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185661 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156446 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-81144 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51929 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12339 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10928 usd
CY2023Q2 us-gaap Revenues
Revenues
155 usd
CY2022Q2 us-gaap Revenues
Revenues
117 usd
us-gaap Revenues
Revenues
480 usd
us-gaap Revenues
Revenues
264 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
141 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
105 usd
us-gaap Gross Profit
GrossProfit
434 usd
us-gaap Gross Profit
GrossProfit
237 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5857 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6854 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27553 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28483 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5857 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
6854 usd
us-gaap Operating Expenses
OperatingExpenses
27553 usd
us-gaap Operating Expenses
OperatingExpenses
28483 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5716 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6749 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-27119 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28246 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
774 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
459 usd
us-gaap Interest Expense
InterestExpense
2096 usd
us-gaap Interest Expense
InterestExpense
1160 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6490 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7208 usd
us-gaap Net Income Loss
NetIncomeLoss
-29215 usd
us-gaap Net Income Loss
NetIncomeLoss
-29406 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5284318 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-14763 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-8904 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-23667 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13294 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-36961 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7208 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-44169 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51929 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-10550 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-62479 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12175 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-74654 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6490 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-81144 usd
us-gaap Net Income Loss
NetIncomeLoss
-29215 usd
us-gaap Net Income Loss
NetIncomeLoss
-29406 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
306 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
307 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1375 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1375 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-47 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-414 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2096 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1160 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28141 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29700 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
28530 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23887 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28530 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23887 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
389 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5813 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1241 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6168 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355 usd
us-gaap Line Of Credit Facility Maximum Amount Outstanding During Period
LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
85000 usd
CY2023Q2 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.035 pure
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
26430 usd
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
78473 usd
CY2022 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
52043 usd
us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
3743 usd
CY2022 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
1909 usd
CY2023Q2 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-12-31
us-gaap Line Of Credit Facility Annual Principal Payment
LineOfCreditFacilityAnnualPrincipalPayment
10826 usd
CY2022 us-gaap Line Of Credit Facility Annual Principal Payment
LineOfCreditFacilityAnnualPrincipalPayment
8726 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001610718

Files In Submission

Name View Source Status
0001213900-23-064517-index-headers.html Edgar Link pending
0001213900-23-064517-index.html Edgar Link pending
0001213900-23-064517.txt Edgar Link pending
0001213900-23-064517-xbrl.zip Edgar Link pending
f10q0623ex10-1_outdoor.htm Edgar Link pending
f10q0623ex10-2_outdoor.htm Edgar Link pending
f10q0623ex31-1_outdoor.htm Edgar Link pending
f10q0623ex32-1_outdoor.htm Edgar Link pending
f10q0623_outdoor.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
osp-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
osp-20230630_lab.xml Edgar Link unprocessable
osp-20230630_pre.xml Edgar Link unprocessable
f10q0623_outdoor_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
osp-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
osp-20230630_cal.xml Edgar Link unprocessable